| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.001 |